MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5114/aoms.2014.42577

Медицинская библиотека · Acta medica Iranica · 2012

Evaluation of nasomaxillary growth of adolescent boys in northeastern Iran.

Reyna-Juárez Yatzil, Mejía-Domínguez Nancy R, Ostos-Prado María José, Alcalá-Carmona Beatriz, Balderas-Miranda Jennifer T, Gaytán Andrés, Hernández-López Agustín, Núñez-Álvarez Carlos A, Baños-Laredo Martha E, Domínguez-López María Lilia, Santana De Anda Karina, Gómez-Martín Diana, Torres-Ruiz Jiram

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

To prospectively address the predictive features of refractory dermatomyositis (DM) and to construct and internally validate a clinical predictive index to timely identify patients at risk of this complication.

METHODS

We recruited 168 patients with DM in a tertiary care centre in Mexico, and prospectively followed them, looking for the primary outcome, which was the diagnosis of refractory disease, defined as persistent disease activity three months after an adequate treatment course with glucocorticoids and at least one immunosuppressant. A logistic regression analysis was performed to calculate the odds ratios (OR) with 95% confidence interval (95% CI) of each predictive feature and to construct the Refractory DermatoMyositis Index (ReDMI).

RESULTS

One hundred twenty-one (72%) patients were women, and the most frequent myositis-specific antibody was Mi2 (23.9%). Fifty-seven patients (33.9%) developed refractory disease. The positivity for anti-TIF1-g (3.76 (1.17-13.3), p=0.029), the gastrointestinal disease activity (visual analogue scale) (1.11 (1.004-1.249), p=0.04), and alopecia (2.5 (1.11-5.7), p=0.026) were the refractoriness predictive factors. ReDMI predicted refractory disease with an OR of 3.57 (95% CI 1.71-7.59), an optimism corrected area under the curve of 0.67 with good internal validity and calibration.

CONCLUSIONS

After external validation, the ReDMI may be a useful clinical tool to timely detect DM patients at risk of developing refractory disease who may be candidates to receive an early more aggressive therapy.

Для цитирования: Reyna-Juárez Yatzil, Mejía-Domínguez Nancy R, Ostos-Prado María José, Alcalá-Carmona Beatriz, Balderas-Miranda Jennifer T, Gaytán Andrés, Hernández-López Agustín, Núñez-Álvarez Carlos A, Baños-Laredo Martha E, Domínguez-López María Lilia, Santana De Anda Karina, Gómez-Martín Diana, Torres-Ruiz Jiram. Evaluation of nasomaxillary growth of adolescent boys in northeastern Iran.. Acta medica Iranica. 2012. DOI: 10.5114/aoms.2014.42577.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.